AR015976A1 - Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento - Google Patents

Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento

Info

Publication number
AR015976A1
AR015976A1 ARP980105251A ARP980105251A AR015976A1 AR 015976 A1 AR015976 A1 AR 015976A1 AR P980105251 A ARP980105251 A AR P980105251A AR P980105251 A ARP980105251 A AR P980105251A AR 015976 A1 AR015976 A1 AR 015976A1
Authority
AR
Argentina
Prior art keywords
manufacture
dry eye
agonists
same
compositions containing
Prior art date
Application number
ARP980105251A
Other languages
English (en)
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of AR015976A1 publication Critical patent/AR015976A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una composicion para el tratamiento del ojo seco en humanos, que comprende una cantidad farmacéuticamente efectiva de uno o más agonista(s) de H2 dehistamina tales como dimaprit, anthamine e impromidine, en un portador farmacéuticamente aceptable; yel uso de la misma para la manufactura de unmedicamento.
ARP980105251A 1997-10-21 1998-10-21 Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento AR015976A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6290697P 1997-10-21 1997-10-21

Publications (1)

Publication Number Publication Date
AR015976A1 true AR015976A1 (es) 2001-05-30

Family

ID=22045617

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105251A AR015976A1 (es) 1997-10-21 1998-10-21 Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento

Country Status (5)

Country Link
US (1) US6274160B1 (es)
AR (1) AR015976A1 (es)
AU (1) AU1104799A (es)
WO (1) WO1999020265A1 (es)
ZA (1) ZA989513B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2546005C2 (ru) 2009-09-15 2015-04-10 Кью Эл Ти ИНК. Фармацевтические составы, содержащие 9-цис-ретиниловые сложные эфиры в липидном наполнителе
BR112012026939A2 (pt) 2010-04-19 2016-07-12 Quadra Logic Tech Inc método para tratamento de um paciente sofrendo da perda ou debilitação da visão
ES2780357T3 (es) 2012-03-01 2020-08-25 Retinagenix Therapeutics Inc Derivados de retinal para usar en la mejora de la función visual

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991759A (en) 1975-10-28 1976-11-16 Alza Corporation Method and therapeutic system for treating aqueous deficient dry eye
US4131651A (en) 1977-10-25 1978-12-26 Barnes-Hind Pharmaceuticals, Inc. Treatment of dry eye
US4409205A (en) 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4370325A (en) 1979-03-30 1983-01-25 Dermik Laboratories Pharmaceutical compositions and method of treatment
US4315024A (en) * 1980-08-08 1982-02-09 Cooper Laboratories, Inc. Compositions and method for treating red eye
US4883658A (en) 1986-04-28 1989-11-28 Holly Frank J Ophthalmic solution for treatment of dry-eye syndrome
US4744980A (en) 1986-04-28 1988-05-17 Holly Frank J Ophthalmic solution for treatment of dry eye syndrome
US4818537A (en) 1986-10-21 1989-04-04 Liposome Technology, Inc. Liposome composition for treating dry eye
US4966773A (en) 1986-11-25 1990-10-30 Alcon Laboratories, Inc. Topical ophthalmic compositions containing microfine retinoid particles
US4914088A (en) 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
US5075104A (en) 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5041434A (en) 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
ATE132366T1 (de) 1990-05-29 1996-01-15 Boston Ocular Res Zusammensetzung zur behandlung von dry eye erkrankungen
DE69212850T2 (de) 1991-01-15 1997-03-06 Alcon Lab Inc Verwendung von Karrageenan in topischen ophthalmologischen Zusammensetzungen
US5294433A (en) 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5290572A (en) 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
BR9203277A (pt) 1992-08-21 1994-03-01 Cesar Roberto Dias Nahoum Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses

Also Published As

Publication number Publication date
WO1999020265A1 (en) 1999-04-29
US6274160B1 (en) 2001-08-14
AU1104799A (en) 1999-05-10
ZA989513B (en) 1999-04-21

Similar Documents

Publication Publication Date Title
YU38802A (sh) Nova kompozicija i njena upotreba
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
AP2002002458A0 (en) Compounds for the treatment of ischemia.
PT1093819E (pt) Compostos e composicoes para fornecimento de agentes activos
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
AR010385A1 (es) Compuesto derivado de propiofenona, proceso para su preparacion, composicion farmaceutica que lo contiene y uso de dicho compuesto.
HUP0103567A3 (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists, process for their preparation and pharmaceutical compositions containing the same
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
AU2855399A (en) Vascularization inhibitors
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
YU13301A (sh) Muskarinski agonisti i antagonisti
SE9802937D0 (sv) Novel compounds
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
SV2008002856A (es) 2-amino-7, 8-dihidro-6h-pirido [4,3-d] pirimidina-5-onas
CL2002001701A1 (es) Uso de al menos un compuesto seleccionado entre melatonina, agentes melatoninergicos, agonistas y antagonistas de melatonina, en una cantidad de 0,0025-50 mg, para preparar un medicamento util para el tratamiento y mejora de la calidad repadora del sueno.
AR015976A1 (es) Composiciones que contienen agonistas de h2 de histamina para el tratamiento del ojo seco y el uso de las mismas en la manufactura de un medicamento
HRP20000781B1 (en) Effervescent preparations
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
ES2185698T3 (es) Composicion de tratamiento anti-acne de la piel.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
AR008154A1 (es) Acido (s)-7-[(4,4&#39;-bipiperidin-1-il)carbonil]-2,3,4,5-tetrahidro-4-metil- -3-oxo-1h-1,4-benzodiazepina-2-acetico, como hidrocloruro del mismo, unacomposicion farmaceutica que lo comprende, el uso del mismo y un procedimiento para su preparacion.
AR017215A1 (es) Composiciones que contienen generadores de oxido nitrico y uso de dichos generadores para la preparacion de un medicamento util para el tratamiento detrastornos de ojo seco
ES2084738T3 (es) Una almohadilla absorbente, un procedimiento para la obtencion de una almohadilla absorbente, y un articulo absorbente desechable.
ES2183205T3 (es) Hcg y derivados en calidad de inhibidores de melaloproteasas de la matriz.